Janux Therapeutics Inc (JANX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 12-2019 | |
| Sales | 380 | 0 | 0 | 0 | 0 |
| Gross Profit | 380 | N/A | N/A | N/A | N/A |
| Operating Expenses | 2,664 | 0 | 1,256 | 1,106 | 0 |
| Operating Income | -2,284 | N/A | -1,256 | -1,106 | N/A |
| Interest Expense | 0 | 0 | 0 | 109 | 0 |
| Other Income | 0 | 0 | 0 | -1,245 | 0 |
| Pre-tax Income | -2,284 | 0 | -1,256 | -2,460 | 0 |
| Net Income Continuous | -2,284 | N/A | -1,256 | -2,460 | N/A |
| Net Income | $-2,284 | $N/A | $-1,256 | $-2,460 | $N/A |
| EPS Basic Total Ops | -2.06 | N/A | -1.33 | -2.76 | N/A |
| EPS Basic Continuous Ops | -2.06 | N/A | -1.33 | -2.76 | N/A |
| EPS Diluted Total Ops | -2.06 | N/A | -1.33 | -2.76 | N/A |
| EPS Diluted Continuous Ops | -2.06 | N/A | -1.33 | -2.76 | N/A |
| EBITDA(a) | $-2,275 | $N/A | $-1,255 | $-1,106 | $N/A |